SGS Biopharma Research Unit Stuivenberg
About SGS Biopharma Research Unit Stuivenberg
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
International Partnership for Microbicides, Inc.
1
Clinical Trials at SGS Biopharma Research Unit Stuivenberg
During the past decade, SGS Biopharma Research Unit Stuivenberg conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years
2004-03-01
2004-05-01
Completed
Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)
2005-05-01
2005-06-01
Completed
A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium
2005-12-01
Completed
36
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at SGS Biopharma Research Unit Stuivenberg
According to Clinical.Site data, the most researched conditions in "SGS Biopharma Research Unit Stuivenberg" are
"Encephalitis, Tick-borne" (2 trials), "HIV Infections" (1 trials) and "HIV-1" (1 trials). Many other conditions were trialed in "SGS Biopharma Research Unit Stuivenberg" in a lesser frequency.
Clinical Trials Intervention Types at SGS Biopharma Research Unit Stuivenberg
Most popular intervention types in "SGS Biopharma Research Unit Stuivenberg" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl" (1 trials), "Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)" (1 trials) and "dapivirine (TMC120) vaginal gel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SGS Biopharma Research Unit Stuivenberg
The vast majority of trials in "SGS Biopharma Research Unit Stuivenberg" are
2 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at SGS Biopharma Research Unit Stuivenberg
Currently, there are NaN active trials in "SGS Biopharma Research Unit Stuivenberg".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in SGS Biopharma Research Unit Stuivenberg,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SGS Biopharma Research Unit Stuivenberg, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".